121.03
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $121.03, with a volume of 1.93M.
It is down -0.71% in the last 24 hours and down -14.62% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$121.90
Open:
$122.59
24h Volume:
1.93M
Relative Volume:
1.19
Market Cap:
$34.51B
Revenue:
$6.53B
Net Income/Loss:
$1.26B
P/E Ratio:
27.82
EPS:
4.35
Net Cash Flow:
$1.31B
1W Performance:
-1.65%
1M Performance:
-14.62%
6M Performance:
-12.74%
1Y Performance:
-17.83%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
A
Agilent Technologies Inc
|
121.03 | 34.51B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
TMO
Thermo Fisher Scientific Inc
|
514.20 | 193.99B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
205.61 | 146.95B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
426.69 | 34.70B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
183.48 | 32.35B | 15.41B | 1.37B | 2.11B | 7.50 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jun-03-24 | Resumed | Jefferies | Hold |
Apr-05-24 | Upgrade | Stifel | Hold → Buy |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
Nov-17-23 | Downgrade | UBS | Buy → Neutral |
Sep-28-23 | Initiated | Bernstein | Mkt Perform |
Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
May-24-23 | Reiterated | Barclays | Equal Weight |
May-24-23 | Reiterated | BofA Securities | Buy |
May-24-23 | Reiterated | Citigroup | Neutral |
May-24-23 | Reiterated | Credit Suisse | Outperform |
May-24-23 | Reiterated | Evercore ISI | Outperform |
May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
May-24-23 | Reiterated | Robert W. Baird | Outperform |
May-24-23 | Reiterated | SVB Securities | Outperform |
May-24-23 | Reiterated | Stifel | Hold |
May-24-23 | Reiterated | TD Cowen | Outperform |
May-24-23 | Reiterated | Wells Fargo | Overweight |
May-11-23 | Initiated | Barclays | Equal Weight |
Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Jul-20-22 | Initiated | UBS | Buy |
Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Feb-23-22 | Reiterated | BofA Securities | Buy |
Feb-23-22 | Reiterated | Citigroup | Buy |
Feb-23-22 | Reiterated | Cowen | Outperform |
Feb-23-22 | Reiterated | Evercore ISI | Outperform |
Feb-23-22 | Reiterated | Stifel | Hold |
Feb-23-22 | Reiterated | Wells Fargo | Overweight |
Nov-23-21 | Reiterated | BofA Securities | Buy |
Nov-23-21 | Reiterated | Cowen | Outperform |
Nov-23-21 | Reiterated | Stifel | Hold |
Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
Dec-02-20 | Initiated | Goldman | Buy |
Nov-25-20 | Upgrade | UBS | Neutral → Buy |
Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-30-20 | Initiated | Atlantic Equities | Neutral |
Aug-19-20 | Reiterated | BofA Securities | Neutral |
Aug-19-20 | Reiterated | Citigroup | Neutral |
Aug-19-20 | Reiterated | Jefferies | Buy |
Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
Aug-19-20 | Reiterated | SVB Leerink | Outperform |
Aug-19-20 | Reiterated | Stifel | Hold |
Aug-19-20 | Reiterated | Wells Fargo | Overweight |
Feb-24-20 | Downgrade | Needham | Buy → Hold |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Neutral |
Nov-26-19 | Reiterated | Needham | Buy |
Nov-15-19 | Initiated | Stifel | Hold |
Oct-18-19 | Downgrade | UBS | Buy → Neutral |
Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035 - GlobeNewswire Inc.
Agilent Technologies, Inc. (NYSE:A) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Amundi Cuts Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Acquired by PNC Financial Services Group Inc. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Steward Partners Investment Advisory LLC - Defense World
Bank Julius Baer & Co. Ltd Zurich Cuts Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
High-Performance Liquid Chromatography Market Top Players - openPR
Agilent’s PD-L1 IHC 28-8 pharmDx gets added indications under EU IVDR1 for NSLC - TipRanks
Andra AP fonden Sells 4,200 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications - 01Net
Agilent's Cancer Diagnostic Kit Receives EU Approval for Two New Indications -March 10, 2025 at 10:21 am EDT - Marketscreener.com
Cytokine Market Projected To Witness Substantial Growth, 2025-2032:Abbott, AB Sciex, Agilent Technologies, - EIN News
Protein Engineering Market Projected To Witness Substantial Growth, 2025-2032: Agilent Technologies Inc., - EIN News
Agilent’s cancer diagnostic kit gains EU approval for new uses By Investing.com - Investing.com South Africa
LGT Capital Partners LTD. Sells 76,620 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
AlphaQuest LLC Purchases 3,933 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Global IR Spectroscopy Market Deep Research 2025-2032 | Agilent Technologies, Inc., Bruker Corporation - openPR
Candriam S.C.A. Sells 4,199 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
State of Michigan Retirement System Sells 2,500 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Assetmark Inc. Boosts Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Callan Family Office LLC Purchases New Shares in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Aigen Investment Management LP Acquires New Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Fisher Asset Management LLC Makes New $665,000 Investment in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Victory Capital Management Inc. Has $289.55 Million Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies (NYSE:A) Sets New 52-Week LowHere's Why - MarketBeat
Agilent Technologies Announces Cash Dividend of 12 Cents per Share - AOL
Agilent Technologies director sells $881,008 in stock By Investing.com - Investing.com Australia
Agilent Technologies director sells $881,008 in stock - Investing.com India
Agilent Argues Federal Circuit Should Revive Its CRISPR Patents - Bloomberg Law
Candriam S.C.A. Reduces Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Lung Cancer Diagnostics Market Forecast Report and Competitive Analysis 2025-2033 Featuring llumina, Abbott, Thermo Fisher Scientific, QIAGEN, Roche, Sanofi, Agilent Technologies, bioMerieux - Yahoo Finance
Quintet Private Bank Europe S.A. Sells 42,245 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Modera Wealth Management LLC Buys 2,053 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Cantillon Capital Management LLC Increases Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom' - Benzinga
Noesis Capital Mangement Corp Grows Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Flputnam Investment Management Co. Lowers Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
55,886 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by SVB Wealth LLC - MarketBeat
Molecular Spectroscopy Market Growth and Future Scope 2025-2032 | Agilent Technologies Inc., Bruker Corporation - openPR
Proficio Capital Partners LLC Acquires Shares of 194,031 Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Tech stock hits 52-week low at $124.07 amid market shifts By Investing.com - Investing.com South Africa
Agilent Tech stock hits 52-week low at $124.07 amid market shifts - Investing.com Australia
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):